Trades on 2 secondary markets
Karius
Karius is an infectious disease diagnostics company that applies clinical metagenomics and machine learning to microbial cell-free DNA (mcfDNA) circulating in the bloodstream, detecting pathogens that conventional culture-based testing misses. Its CLIA-certified and CAP-accredited laboratory runs th
Karius is an API provider whose private shares are listed on 2 secondary markets: Hiive, EquityZen.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.